XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Comprehensive Loss - USD ($)
 4 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2020
Jun. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Continuing operations        
Revenue $ 905,049
Cost of sales (1,048,354)
Research and development expense (179,061) (601,942) (1,351,217) (985,158)
Marketing expense (10,938) (80,221) (256,421) (105,060)
Administrative expense (127,886) (820,946) (4,808,655) (2,523,230)
Other operating expense (2,639) (93,252) (94,207) (38,985)
Loss from operations (320,524) (1,596,361) (6,653,805) (3,652,433)
Share of loss from associate (390,453)
Financial Cost (160,035) (2,130)
Other financial results 1,030,525 (872,342)
Transaction expenses (3,535,046)
Share based payment cost of listing shares (42,705,061)
Net loss before Income tax (320,524) (1,986,814) (52,023,422) (4,526,905)
Income tax benefit 234,542
Net loss of the year $ (320,524) $ (1,986,814) $ (51,788,880) $ (4,526,905)
Basic and diluted loss per share (in Dollars per share) $ (0.01) $ (0.07) $ (1.5) $ (0.15)
Other comprehensive income/loss        
Net loss of the year $ (320,524) $ (1,986,814) $ (51,788,880) $ (4,526,905)
Foreign exchange differences on translation of foreign operations 18,112
Total other comprehensive income/(loss) 18,112
Total comprehensive loss for the year $ (320,524) $ (1,986,814) $ (51,770,768) $ (4,526,905)